Kdoqi Clinical Practice Guidelines And Clinical Practice Recommendations For Anemia In Chronic Kidney Disease

AJKD

VOL 47, NO 5, SUPPL 3, MAY 2006

American Journal of Kidney Diseases

CONTENTS

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease
Tables ............................................................................................................................... Figures............................................................................................................................. Abbreviations and Acronyms ........................................................................................ Work Group Membership ............................................................................................... KDOQI Advisory Board Members.................................................................................. Foreword .......................................................................................................................... I. EXECUTIVE SUMMARY II. CLINICAL PRACTICE GUIDELINES AND CLINICAL PRACTICE RECOMMENDATIONS FOR ANEMIA IN CHRONIC KIDNEY DISEASE IN ADULTS

S1 S2 S4 S7 S8 S9 S11 S16 S17 S28 S33 S54 S58 S71 S79 S81 S86 S87 S89 S90

1.1. Identifying Patientsand Initiating Evaluation .................................................... 1.2. Evaluation of Anemia in CKD............................................................................. 2.1. Hb Range ............................................................................................................ 3.1. Using ESAs......................................................................................................... 3.2. Using Iron Agents............................................................................................... 3.3. Using Pharmacological and Nonpharmacological Adjuvants to ESA Treatment in HD-CKD......................................................................................................... 3.4. Transfusion Therapy.......................................................................................... 3.5. Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb.......................................................................................................................
III. CLINICAL PRACTICE RECOMMENDATIONS FOR ANEMIA IN CHRONIC KIDNEY DISEASE IN CHILDREN

1.1: Identifying Patients and InitiatingEvaluation .................................................... 1.2: Evaluation of Anemia in CKD............................................................................. 2.1: Hb Range ............................................................................................................

3.1: Using ESAs......................................................................................................... 3.2: Using Iron Agents............................................................................................... 3.3: Using Pharmacological and NonPharmacological Adjuvants to ESA Treatment in HD-CKD......................................................................................................... 3.4: Transfusion Therapy.......................................................................................... 3.5: Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb Level .............................................................................................................
IV. CLINICAL PRACTICE RECOMMENDATIONS FOR ANEMIA IN CHRONIC KIDNEY DISEASE IN TRANSPLANT RECIPIENTS V. APPENDIX 1: METHODS OF EVIDENCE REVIEW AND SYNTHESIS................... Work Group Biographies............................................................................................. Acknowledgments ....................................................................................................... References....................................................................................................................

S93 S99 S105...